查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2150064

微生理系統市場：全球市場預測，2026-2032年

Microphysiological System Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，微生理系統市場將成長至 4.9801 億美元，複合年成長率為 17.18%。

主要市場統計數據
基準年 2025 1.6407億美元
預計年份：2026年 1.9072億美元
預測年份 2032 4.9801億美元
複合年成長率 (%) 17.18%

微生理系統概述

微生理系統（MPS）是一種體外平台，旨在複製人體組織和器官的特定結構、力學、生化和功能特徵。它們通常被稱為「晶片器官」或「晶片組織」系統，結合了人類細胞、生物材料、微流體技術、感測器和計算分析，以支援研發、安全性評估和轉化應用。其價值在於能夠產生與人體相關的證據，同時減少對傳統2D培養和特定動物實驗的依賴。其應用進展仍取決於生物學可重複性、方案標準化、驗證要求、法規核准、工作流程整合以及專家知識的可用性。

從靜態細胞模型到與人類相關的實驗平台

該領域正從孤立的概念驗證（PoC）設備轉向更具可重複性的平台，旨在貫穿整個研發流程並可重複使用。關鍵變化包括更多使用原代和幹細胞衍生的人類細胞、多細胞共培養、灌注組織模型、整合感測和連接器官系統。研究人員也更加重視標準化操作規程、參考材料、機構間比較以及模型限制的透明報告。這些進展使得MPS不再是現有方法的獨立替代品，而是作為標靶驗證、毒性評估、疾病建模、藥理學和個人化研究的補充工具。

人工智慧增強了模型設計、解釋和品管。

人工智慧正透過影像分析、時間序列資料解讀、實驗最佳化和組織反應預測等方式影響著微物理系統（MPS）。機器學習技術有助於量化形態、屏障功能、收縮性、電生理特性、代謝活性以及其他難以透過人工審核進行一致評估的表現型訊號。數位孿生和機制模型的概念可能進一步幫助整合來自多種組織和實驗條件的數據。然而，有效利用人工智慧需要正確標註的資料集、一致的檢測流程、可解釋的輸出結果、解決批次效應的措施以及獨立的檢驗。雖然人工智慧可以加速分析並提高可重複性，但它並不能取代生物學對照、專業知識或監管審查。

區域洞察：法規、基礎設施和實用化推動普及

在北美，生物醫學研究能力、生物技術活動以及對替代檢測方法的興趣都十分強勁，但其應用受到檢驗和監管預期的影響。歐洲受益於合作研究網路、先進的生命科學基礎設施以及對非動物實驗法律的重視，但跨境標準化仍然至關重要。在亞太地區，澳洲、中國、印度、日本和韓國的發展呈現多樣化的態勢，這得益於先進的製造業、藥物研發和公共部門科學計畫的支持。包括巴西和墨西哥在內的拉丁美洲正透過與學術機構、製藥公司和轉化研究機構的夥伴關係來提升自身能力，但專業設備和資金的取得並不均衡。在中東，研發能力正在特定地區逐步建立；而在非洲，儘管基礎設施、人力資源開發和採購方面存在諸多限制，但人們仍期望能夠建立區域性疾病模型並進行合作研發。

群體洞察：協作網路加速標準化

東南亞國協可受益於通用方案、區域培訓和合作生物銀行，以減少正在開發的MPS專案中的重複工作。金磚國家成員國擁有豐富的科學和臨床多樣性，會發現合作檢驗研究和區域相關疾病模型特別重要。歐盟為成員國之間的協調研發、文件統一和監管對話提供了一個框架。七國集團擁有成熟的生物醫學生態系統、先進的測量設備和政策參與，但仍需持續協調，以實現跨司法管轄區的證據互通性。海灣合作理事會成員國可透過集中式研究設施、投資轉化研究以及與國際組織夥伴關係來支持實施。北約成員國更多地被視為研究和技術網路，而非單一的監管市場，因此可受益於互通標準以及在生物安全、韌性和先進生物醫學工程方面的專業知識共用。

國家洞察：多元化能力創造互補角色

美國和加拿大在生物醫學工程、藥物研發和轉化研究領域實力雄厚。英國、德國、法國、義大利和西班牙透過大學主導的創新、藥物研究和歐洲合作計畫做出貢獻，其中協調一致的驗證仍然是重中之重。日本和韓國結合先進的電子、材料科學和生命科學能力，為感測器整合和自動化平台提供支援。中國正在拓展其在微流體、細胞生物學和製藥領域的研發能力。印度正透過與學術界、生技界和製藥業的合作，培養微處理器系統（MPS）的專業技術，而澳洲則憑藉強大的生物醫學研究和轉化科學能力做出貢獻。巴西和墨西哥是拉丁美洲的重要貢獻者，為將學術能力與產業檢驗相結合提供了機會。俄羅斯擁有相關的科學專長，但國際合作、設備取得和監管協調可能會影響其應用。

行業優先事項：建立一個檢驗、互通性且易於使用的決策平台。

產業領導者應優先考慮明確的用例，並根據所需支援的決策選擇合適的模型複雜度。在規模化部署之前，建立標準化的協定、驗收標準、品管和已記錄的效能特徵至關重要。各組織應組成涵蓋生物學、工程學、資料科學、毒理學、藥理學和法規事務等領域的跨領域團隊。與學術機構、合約研究組織 (CRO)、技術開發商和公共機構夥伴關係，可以改善檢驗並降低部署風險。領導者還應投資於可互通的數據系統、人工智慧管治、員工培訓以及將 MPS 結果與已建立的臨床、臨床前和監管終點聯繫起來的證據包。分階段實施——試點實施、可重複性測試、基準測試和整合——為負責任的部署提供了一條切實可行的途徑。

調查方法：基於證據的MPS現況綜合分析

本執行摘要基於對微生理系統 (MPS) 領域的系統性回顧，圍繞著技術發展、應用、底層基礎設施、法規、人工智慧和區域部署條件。證據評估應採用同行評審的研究、監管和標準出版刊物、政府或政府間機構資料、檢驗的技術文件以及相關臨床或轉化研究記錄。研究結果在特定區域、國家組和國家層級進行相對解讀，並考慮了科學基礎、資金籌措、製造、政策和部署準備的差異。由於平台性能可能因組織類型、細胞來源、設備架構和檢測終點而異，因此結論應區分已驗證的功能和新興潛力，避免將所有 MPS 形式視為可互換。

結論：轉化研究依賴可靠的證據和實際應用。

微生理系統正日益成為研發、安全性評估和治療開發中，為人類提供更具相關性的生物學證據的關鍵工具。其長期貢獻更取決於可重複性、標準化、透明檢驗以及與現有決策流程的兼容性，而非單純的新穎性。區域和國家優勢相輔相成，為方案共用、跨國基準測試和負責任的資料整合創造了機會。只要數據品質、可解釋性和生物有效性始終是核心，人工智慧就能進一步拓展微生理系統的效用。擁有明確應用領域並專注於決策證據的機構，將更有能力將技術進步轉化為可靠的科學和營運價值。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：微生理系統市場：依技術分類

  • Organ On Chip
  • 類器官
  • 微流體
  • 3D生物列印
  • 球體

第8章：微生理系統市場：依系統類型分類

  • 單一器官模型
  • 多重器官（晶片人體）系統

第9章：微生理系統市場：依調查模型

  • 人類細胞單核細胞增生症
  • 動物細胞單核細胞生成系統
  • 利用幹細胞（iPSCs）的模型
  • 混合/器官型模型

第10章：微生理系統市場：依產品/服務分類

  • 系統/解決方案
  • 服務
  • 消耗品

第11章 微生理系統市場：依應用分類

  • 藥物發現與篩檢
  • 疾病建模
  • 毒理學和安全性評估
  • 個人化醫療
  • 監管測試
  • 生物利用度和療效研究

第12章 微生理系統市場：依最終用戶分類

  • 製藥和生物技術公司
  • 學術研究機構
  • 受託研究機構（CRO）
  • 政府和監管機構
  • 醫院和臨床研究中心

第13章：微生理系統市場：依部署模式分類

  • 建立內部實驗室
  • MPS服務外包

第14章 微生理系統市場：依地區分類

  • 亞太地區
  • 歐洲
  • 北美洲
  • 拉丁美洲
  • 非洲
  • 中東

第15章 微生理系統市場：依組別分類

  • NATO
  • G7
  • EU
  • BRICS
  • ASEAN
  • GCC

第16章 微生理系統市場：依國家分類

  • 美國
  • 中國
  • 德國
  • 日本
  • 印度
  • 英國
  • 法國
  • 加拿大
  • 義大利
  • 澳洲
  • 巴西
  • 韓國
  • 墨西哥
  • 俄羅斯
  • 西班牙

第17章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第18章：公司簡介

  • Emulate, Inc.
  • CN Bio Innovations Ltd.
  • InSphero AG
  • TissUse GmbH
  • MIMETAS BV
  • Hesperos, Inc.
  • SynVivo, Inc.
  • Cherry Biotech SAS
  • BioIVT LLC
  • Kirkstall Ltd.
  • AIM Biotech Pte. Ltd.
  • Altis Biosystems, Inc.
  • AlveoliX AG
  • Ananda Devices
  • Beijing Daxiang Biotech Co., Ltd
  • BI/OND Solutions BV
  • BiomimX Srl
  • FUJIFILM Cellular Dynamics
  • ImmuONE
  • Netri, Inc.
  • Obatala Sciences, Inc.
  • Quris Technologies LTD
  • React4life SpA
  • Valo Health, Inc.

第19章 主要專家

Product Code: MRR-3D150775E6EA

The Microphysiological System Market is projected to grow by USD 498.01 million at a CAGR of 17.18% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 164.07 million
Estimated Year [2026] USD 190.72 million
Forecast Year [2032] USD 498.01 million
CAGR (%) 17.18%

Microphysiological Systems: Executive Overview

Microphysiological systems (MPS) are engineered in vitro platforms that reproduce selected structural, mechanical, biochemical, and functional features of human tissues or organs. Often described as organ-on-chip or tissue-on-chip systems, they combine human cells, biomaterials, microfluidics, sensors, and computational analysis to support research, safety assessment, and translational development. Their value lies in generating human-relevant evidence while reducing dependence on conventional two-dimensional cultures and selected animal studies. Adoption remains shaped by biological reproducibility, protocol standardization, validation requirements, regulatory acceptance, workflow integration, and the availability of specialized expertise.

From Static Cell Models to Human-Relevant Experimental Platforms

The field is shifting from isolated proof-of-concept devices toward more reproducible platforms designed for repeatable use across research and development workflows. Important changes include greater use of primary and stem-cell-derived human cells, multicellular co-culture, perfused tissue models, integrated sensing, and linked organ systems. Researchers are also placing greater emphasis on standardized operating procedures, reference materials, interlaboratory comparison, and transparent reporting of model limitations. These developments are helping position MPS as complementary tools for target validation, toxicity assessment, disease modeling, pharmacology, and personalized research rather than as standalone replacements for every existing method.

Artificial Intelligence Strengthens Model Design, Interpretation, and Quality Control

Artificial intelligence is influencing MPS through image analysis, time-series interpretation, experimental optimization, and prediction of tissue responses. Machine-learning methods can help quantify morphology, barrier integrity, contractility, electrophysiology, metabolic activity, and other phenotypic signals that are difficult to evaluate consistently by manual review. Digital-twin concepts and mechanistic models may further support integration of data from multiple tissues and experimental conditions. However, useful deployment depends on well-annotated datasets, consistent assay procedures, explainable outputs, protection against batch effects, and independent validation. AI can accelerate analysis and improve reproducibility, but it does not remove the need for biological controls, domain expertise, or regulatory scrutiny.

Regional Insights: Regulation, Infrastructure, and Translation Shape Adoption

North America combines strong biomedical research capacity, biotechnology activity, and interest in alternative testing approaches, while implementation is influenced by validation and regulatory expectations. Europe benefits from coordinated research networks, advanced life-science infrastructure, and policy attention to non-animal methods, with cross-border standardization remaining important. Asia-Pacific shows diverse development across Australia, China, India, Japan, and South Korea, supported by advanced manufacturing, pharmaceutical research, and public-sector science programs. Latin America, including Brazil and Mexico, is developing capabilities through academic, pharmaceutical, and translational partnerships, although access to specialized equipment and funding can vary. The Middle East is building research and innovation capacity in selected hubs, while Africa presents opportunities for locally relevant disease models and collaborative development alongside constraints related to infrastructure, training, and procurement.

Group Insights: Collaboration Networks Accelerate Standardization

ASEAN economies can benefit from shared protocols, regional training, and collaborative biobanking that reduce duplication across developing MPS programs. BRICS members offer substantial scientific and clinical diversity, making joint validation studies and locally relevant disease models particularly valuable. The European Union provides a framework for coordinated research, harmonized documentation, and regulatory dialogue across member states. G7 countries contribute mature biomedical ecosystems, advanced instrumentation, and policy engagement, but continued alignment is needed to make evidence portable between jurisdictions. GCC members can support adoption through centralized research facilities, translational investment, and partnerships with international institutions. NATO countries, viewed as a research and technology network rather than a single regulatory market, may gain from interoperable standards and shared expertise in biosafety, resilience, and advanced biomedical engineering.

Country Insights: Diverse Capabilities Create Complementary Roles

The United States and Canada have established strengths in biomedical engineering, drug development, and translational research. The United Kingdom, Germany, France, Italy, and Spain contribute through university-led innovation, pharmaceutical research, and European collaborative programs, with harmonized validation remaining a priority. Japan and South Korea combine advanced electronics, materials science, and life-science capabilities, supporting sensor integration and automated platforms. China is expanding research and manufacturing capacity across microfluidics, cell biology, and pharmaceutical applications. India is developing MPS expertise through academic, biotechnology, and pharmaceutical collaborations, while Australia contributes strong biomedical research and translational science. Brazil and Mexico are important Latin American contributors, with opportunities to connect academic capability to industrial validation. Russia maintains relevant scientific expertise, although international collaboration, access to equipment, and regulatory connectivity can affect deployment.

Industry Priorities: Build Validated, Interoperable, and Decision-Ready Platforms

Industry leaders should prioritize clearly defined use cases and select model complexity according to the decision being supported. Establishing standardized protocols, acceptance criteria, quality controls, and documented performance characteristics is essential before scaling deployment. Organizations should create multidisciplinary teams spanning biology, engineering, data science, toxicology, pharmacology, and regulatory affairs. Partnerships with academic centers, contract research organizations, technology developers, and public agencies can improve validation and reduce implementation risk. Leaders should also invest in interoperable data systems, AI governance, staff training, and evidence packages that connect MPS outputs with established clinical, preclinical, and regulatory endpoints. A staged approach-pilot, reproduce, benchmark, then integrate-offers a practical path to responsible adoption.

Research Methodology: Evidence-Based Synthesis of the MPS Landscape

This executive summary is based on a structured review of the microphysiological systems field, organized around technology development, applications, enabling infrastructure, regulation, artificial intelligence, and geographic adoption conditions. Evidence should be assessed using peer-reviewed studies, regulatory and standards publications, government or intergovernmental materials, validated technical documentation, and relevant clinical or translational research records. Findings are interpreted comparatively across the specified regions, country groups, and countries, with attention to differences in scientific capacity, funding, manufacturing, policy, and implementation readiness. Because platform performance can vary by tissue type, cell source, device architecture, and assay endpoint, conclusions should distinguish demonstrated capabilities from emerging possibilities and avoid treating all MPS formats as interchangeable.

Conclusion: Translation Depends on Trustworthy Evidence and Practical Integration

Microphysiological systems are becoming important tools for producing more human-relevant biological evidence across research, safety, and therapeutic development. Their long-term contribution will depend less on novelty alone than on reproducibility, standardization, transparent validation, and compatibility with existing decision processes. Regional and country-level strengths are complementary, creating opportunities for shared protocols, cross-border benchmarking, and responsible data integration. Artificial intelligence can extend the usefulness of MPS, provided that data quality, interpretability, and biological validation remain central. Organizations that focus on clearly defined applications and decision-ready evidence will be best positioned to convert technological progress into reliable scientific and operational value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Microphysiological System Market, by Technology

  • 7.1. Introduction
  • 7.2. Organ On Chip
  • 7.3. Organoids
  • 7.4. Microfluidics
  • 7.5. 3D Bioprinting
  • 7.6. Spheroids

8. Microphysiological System Market, by System Type

  • 8.1. Introduction
  • 8.2. Single-organ models
  • 8.3. Multi-organ (body-on-a-chip) systems

9. Microphysiological System Market, by Research Model

  • 9.1. Introduction
  • 9.2. Human cell-based MPS
  • 9.3. Animal cell-based MPS
  • 9.4. Stem cell (iPSC) based models
  • 9.5. Hybrid/organotypic models

10. Microphysiological System Market, by Offering

  • 10.1. Introduction
  • 10.2. System/Solution
  • 10.3. Services
  • 10.4. Consumables

11. Microphysiological System Market, by Application

  • 11.1. Introduction
  • 11.2. Drug discovery & screening
  • 11.3. Disease modeling
  • 11.4. Toxicology & safety assessment
  • 11.5. Personalized medicine
  • 11.6. Regulatory testing
  • 11.7. Bioavailability & efficacy studies

12. Microphysiological System Market, by End User

  • 12.1. Introduction
  • 12.2. Pharmaceutical & biotechnology companies
  • 12.3. Academic & research institutes
  • 12.4. Contract Research Organizations (CROs)
  • 12.5. Government & regulatory agencies
  • 12.6. Hospitals & clinical research centers

13. Microphysiological System Market, by Deployment Mode

  • 13.1. Introduction
  • 13.2. In-house lab installations
  • 13.3. Outsourced MPS services

14. Microphysiological System Market, by Region

  • 14.1. Introduction
  • 14.2. Asia-Pacific
  • 14.3. Europe
  • 14.4. North America
  • 14.5. Latin America
  • 14.6. Africa
  • 14.7. Middle East

15. Microphysiological System Market, by Group

  • 15.1. Introduction
  • 15.2. NATO
  • 15.3. G7
  • 15.4. European Union
  • 15.5. BRICS
  • 15.6. ASEAN
  • 15.7. GCC

16. Microphysiological System Market, by Country

  • 16.1. Introduction
  • 16.2. United States
  • 16.3. China
  • 16.4. Germany
  • 16.5. Japan
  • 16.6. India
  • 16.7. United Kingdom
  • 16.8. France
  • 16.9. Canada
  • 16.10. Italy
  • 16.11. Australia
  • 16.12. Brazil
  • 16.13. South Korea
  • 16.14. Mexico
  • 16.15. Russia
  • 16.16. Spain

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2025
  • 17.2. Market Concentration Analysis, 2025
    • 17.2.1. Concentration Ratio (CR)
    • 17.2.2. Herfindahl Hirschman Index (HHI)
  • 17.3. Recent Developments & Impact Analysis, 2025
  • 17.4. Product Portfolio Analysis, 2025
  • 17.5. Benchmarking Analysis, 2025

18. Company Profiles

  • 18.1. Emulate, Inc.
  • 18.2. CN Bio Innovations Ltd.
  • 18.3. InSphero AG
  • 18.4. TissUse GmbH
  • 18.5. MIMETAS BV
  • 18.6. Hesperos, Inc.
  • 18.7. SynVivo, Inc.
  • 18.8. Cherry Biotech SAS
  • 18.9. BioIVT LLC
  • 18.10. Kirkstall Ltd.
  • 18.11. AIM Biotech Pte. Ltd.
  • 18.12. Altis Biosystems, Inc.
  • 18.13. AlveoliX AG
  • 18.14. Ananda Devices
  • 18.15. Beijing Daxiang Biotech Co., Ltd
  • 18.16. BI/OND Solutions B.V.
  • 18.17. BiomimX S.r.l.
  • 18.18. FUJIFILM Cellular Dynamics
  • 18.19. ImmuONE
  • 18.20. Netri, Inc.
  • 18.21. Obatala Sciences, Inc.
  • 18.22. Quris Technologies LTD
  • 18.23. React4life S.p.A.
  • 18.24. Valo Health, Inc.

19. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Microphysiological System Market, Years Considered for the Study
  • FIGURE 2. Global Microphysiological System Market, Research Design
  • FIGURE 3. Global Microphysiological System Market, Research Framework
  • FIGURE 4. Global Microphysiological System Market, Data Triangulation
  • FIGURE 5. Global Microphysiological System Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Microphysiological System Market Size, by Technology, 2025 vs 2032 (%)
  • FIGURE 7. Global Microphysiological System Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Microphysiological System Market Size, by System Type, 2025 vs 2032 (%)
  • FIGURE 9. Global Microphysiological System Market Size, by System Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Microphysiological System Market Size, by Research Model, 2025 vs 2032 (%)
  • FIGURE 11. Global Microphysiological System Market Size, by Research Model, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Microphysiological System Market Size, by Offering, 2025 vs 2032 (%)
  • FIGURE 13. Global Microphysiological System Market Size, by Offering, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Microphysiological System Market Size, by Application, 2025 vs 2032 (%)
  • FIGURE 15. Global Microphysiological System Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Microphysiological System Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 17. Global Microphysiological System Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Microphysiological System Market Size, by Deployment Mode, 2025 vs 2032 (%)
  • FIGURE 19. Global Microphysiological System Market Size, by Deployment Mode, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 20. Global Microphysiological System Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 21. Global Microphysiological System Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 22. Global Microphysiological System Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 23. Global Microphysiological System Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 24. Global Microphysiological System Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 25. Global Microphysiological System Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Microphysiological System Market Segmentation & Coverage
  • TABLE 2. Global Microphysiological System Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 4. Global Organ On Chip Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Organ On Chip Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Organ On Chip Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Organoids Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Organoids Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Organoids Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Microfluidics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Microfluidics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Microfluidics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global 3D Bioprinting Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global 3D Bioprinting Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global 3D Bioprinting Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Spheroids Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global Spheroids Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global Spheroids Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
  • TABLE 20. Global Single-organ models Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 21. Global Single-organ models Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 22. Global Single-organ models Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 23. Global Multi-organ (body-on-a-chip) systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 24. Global Multi-organ (body-on-a-chip) systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 25. Global Multi-organ (body-on-a-chip) systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 26. Global Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
  • TABLE 27. Global Human cell-based MPS Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 28. Global Human cell-based MPS Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 29. Global Human cell-based MPS Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 30. Global Animal cell-based MPS Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 31. Global Animal cell-based MPS Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 32. Global Animal cell-based MPS Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 33. Global Stem cell (iPSC) based models Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 34. Global Stem cell (iPSC) based models Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 35. Global Stem cell (iPSC) based models Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 36. Global Hybrid/organotypic models Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 37. Global Hybrid/organotypic models Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 38. Global Hybrid/organotypic models Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 39. Global Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
  • TABLE 40. Global System/Solution Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 41. Global System/Solution Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 42. Global System/Solution Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 43. Global Services Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 44. Global Services Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 45. Global Services Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 46. Global Consumables Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 47. Global Consumables Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 48. Global Consumables Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 49. Global Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 50. Global Drug discovery & screening Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 51. Global Drug discovery & screening Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 52. Global Drug discovery & screening Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 53. Global Disease modeling Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 54. Global Disease modeling Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 55. Global Disease modeling Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 56. Global Toxicology & safety assessment Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 57. Global Toxicology & safety assessment Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 58. Global Toxicology & safety assessment Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 59. Global Personalized medicine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 60. Global Personalized medicine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 61. Global Personalized medicine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 62. Global Regulatory testing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 63. Global Regulatory testing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 64. Global Regulatory testing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 65. Global Bioavailability & efficacy studies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 66. Global Bioavailability & efficacy studies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 67. Global Bioavailability & efficacy studies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 68. Global Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 69. Global Pharmaceutical & biotechnology companies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 70. Global Pharmaceutical & biotechnology companies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 71. Global Pharmaceutical & biotechnology companies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 72. Global Academic & research institutes Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 73. Global Academic & research institutes Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 74. Global Academic & research institutes Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 75. Global Contract Research Organizations (CROs) Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 76. Global Contract Research Organizations (CROs) Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 77. Global Contract Research Organizations (CROs) Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 78. Global Government & regulatory agencies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 79. Global Government & regulatory agencies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 80. Global Government & regulatory agencies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 81. Global Hospitals & clinical research centers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 82. Global Hospitals & clinical research centers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 83. Global Hospitals & clinical research centers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 84. Global Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 85. Global In-house lab installations Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 86. Global In-house lab installations Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 87. Global In-house lab installations Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 88. Global Outsourced MPS services Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 89. Global Outsourced MPS services Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 90. Global Outsourced MPS services Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 91. Global Microphysiological System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 92. Asia-Pacific Microphysiological System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 93. Asia-Pacific Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 94. Asia-Pacific Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
  • TABLE 95. Asia-Pacific Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
  • TABLE 96. Asia-Pacific Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
  • TABLE 97. Asia-Pacific Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 98. Asia-Pacific Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 99. Asia-Pacific Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 100. Europe Microphysiological System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 101. Europe Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 102. Europe Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
  • TABLE 103. Europe Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
  • TABLE 104. Europe Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
  • TABLE 105. Europe Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 106. Europe Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 107. Europe Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 108. North America Microphysiological System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 109. North America Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 110. North America Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
  • TABLE 111. North America Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
  • TABLE 112. North America Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
  • TABLE 113. North America Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 114. North America Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 115. North America Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 116. Latin America Microphysiological System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 117. Latin America Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 118. Latin America Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
  • TABLE 119. Latin America Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
  • TABLE 120. Latin America Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
  • TABLE 121. Latin America Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 122. Latin America Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 123. Latin America Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 124. Africa Microphysiological System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 125. Africa Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 126. Africa Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
  • TABLE 127. Africa Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
  • TABLE 128. Africa Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
  • TABLE 129. Africa Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 130. Africa Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 131. Africa Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 132. Middle East Microphysiological System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 133. Middle East Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 134. Middle East Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
  • TABLE 135. Middle East Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
  • TABLE 136. Middle East Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
  • TABLE 137. Middle East Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 138. Middle East Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 139. Middle East Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 140. Global Microphysiological System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 141. NATO Microphysiological System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 142. NATO Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 143. NATO Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
  • TABLE 144. NATO Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
  • TABLE 145. NATO Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
  • TABLE 146. NATO Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 147. NATO Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 148. NATO Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 149. G7 Microphysiological System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 150. G7 Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 151. G7 Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
  • TABLE 152. G7 Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
  • TABLE 153. G7 Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
  • TABLE 154. G7 Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 155. G7 Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 156. G7 Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 157. European Union Microphysiological System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 158. European Union Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 159. European Union Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
  • TABLE 160. European Union Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
  • TABLE 161. European Union Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
  • TABLE 162. European Union Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 163. European Union Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 164. European Union Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 165. BRICS Microphysiological System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 166. BRICS Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 167. BRICS Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
  • TABLE 168. BRICS Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
  • TABLE 169. BRICS Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
  • TABLE 170. BRICS Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 171. BRICS Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 172. BRICS Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 173. ASEAN Microphysiological System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 174. ASEAN Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 175. ASEAN Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
  • TABLE 176. ASEAN Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
  • TABLE 177. ASEAN Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
  • TABLE 178. ASEAN Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 179. ASEAN Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 180. ASEAN Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 181. GCC Microphysiological System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 182. GCC Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 183. GCC Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
  • TABLE 184. GCC Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
  • TABLE 185. GCC Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
  • TABLE 186. GCC Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 187. GCC Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 188. GCC Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 189. Global Microphysiological System Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 190. United States Microphysiological System Market Size, 2017-2032 (USD Million)
  • TABLE 191. United States Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 192. United States Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
  • TABLE 193. United States Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
  • TABLE 194. United States Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
  • TABLE 195. United States Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 196. United States Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 197. United States Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 198. China Microphysiological System Market Size, 2017-2032 (USD Million)
  • TABLE 199. China Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 200. China Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
  • TABLE 201. China Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
  • TABLE 202. China Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
  • TABLE 203. China Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 204. China Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 205. China Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 206. Germany Microphysiological System Market Size, 2017-2032 (USD Million)
  • TABLE 207. Germany Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 208. Germany Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
  • TABLE 209. Germany Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
  • TABLE 210. Germany Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
  • TABLE 211. Germany Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 212. Germany Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 213. Germany Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 214. Japan Microphysiological System Market Size, 2017-2032 (USD Million)
  • TABLE 215. Japan Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 216. Japan Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
  • TABLE 217. Japan Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
  • TABLE 218. Japan Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
  • TABLE 219. Japan Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 220. Japan Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 221. Japan Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 222. India Microphysiological System Market Size, 2017-2032 (USD Million)
  • TABLE 223. India Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 224. India Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
  • TABLE 225. India Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
  • TABLE 226. India Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
  • TABLE 227. India Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 228. India Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 229. India Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 230. United Kingdom Microphysiological System Market Size, 2017-2032 (USD Million)
  • TABLE 231. United Kingdom Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 232. United Kingdom Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
  • TABLE 233. United Kingdom Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
  • TABLE 234. United Kingdom Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
  • TABLE 235. United Kingdom Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 236. United Kingdom Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 237. United Kingdom Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 238. France Microphysiological System Market Size, 2017-2032 (USD Million)
  • TABLE 239. France Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 240. France Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
  • TABLE 241. France Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
  • TABLE 242. France Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
  • TABLE 243. France Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 244. France Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 245. France Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 246. Canada Microphysiological System Market Size, 2017-2032 (USD Million)
  • TABLE 247. Canada Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 248. Canada Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
  • TABLE 249. Canada Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
  • TABLE 250. Canada Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
  • TABLE 251. Canada Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 252. Canada Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 253. Canada Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 254. Italy Microphysiological System Market Size, 2017-2032 (USD Million)
  • TABLE 255. Italy Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 256. Italy Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
  • TABLE 257. Italy Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
  • TABLE 258. Italy Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
  • TABLE 259. Italy Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 260. Italy Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 261. Italy Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 262. Australia Microphysiological System Market Size, 2017-2032 (USD Million)
  • TABLE 263. Australia Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 264. Australia Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
  • TABLE 265. Australia Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
  • TABLE 266. Australia Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
  • TABLE 267. Australia Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 268. Australia Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 269. Australia Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 270. Brazil Microphysiological System Market Size, 2017-2032 (USD Million)
  • TABLE 271. Brazil Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 272. Brazil Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
  • TABLE 273. Brazil Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
  • TABLE 274. Brazil Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
  • TABLE 275. Brazil Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 276. Brazil Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 277. Brazil Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 278. South Korea Microphysiological System Market Size, 2017-2032 (USD Million)
  • TABLE 279. South Korea Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 280. South Korea Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
  • TABLE 281. South Korea Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
  • TABLE 282. South Korea Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
  • TABLE 283. South Korea Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 284. South Korea Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 285. South Korea Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 286. Mexico Microphysiological System Market Size, 2017-2032 (USD Million)
  • TABLE 287. Mexico Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 288. Mexico Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
  • TABLE 289. Mexico Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
  • TABLE 290. Mexico Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
  • TABLE 291. Mexico Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 292. Mexico Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 293. Mexico Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 294. Russia Microphysiological System Market Size, 2017-2032 (USD Million)
  • TABLE 295. Russia Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 296. Russia Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
  • TABLE 297. Russia Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
  • TABLE 298. Russia Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
  • TABLE 299. Russia Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 300. Russia Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 301. Russia Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 302. Spain Microphysiological System Market Size, 2017-2032 (USD Million)
  • TABLE 303. Spain Microphysiological System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 304. Spain Microphysiological System Market Size, by System Type, 2017-2032 (USD Million)
  • TABLE 305. Spain Microphysiological System Market Size, by Research Model, 2017-2032 (USD Million)
  • TABLE 306. Spain Microphysiological System Market Size, by Offering, 2017-2032 (USD Million)
  • TABLE 307. Spain Microphysiological System Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 308. Spain Microphysiological System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 309. Spain Microphysiological System Market Size, by Deployment Mode, 2017-2032 (USD Million)
  • TABLE 310. Global Microphysiological System Market Share, by Key Player, 2025
  • TABLE 311. Global Microphysiological System Market, Key Experts